Pine River Capital Management’s Argos Therapeutics, Inc. ARGS Stock Holding History

Pine River Capital Management’s Portfolio ARGS Stock Details ARGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-11,921	Closed	-$1.92M	–	1135
2014 Q2	$1.92M	Sell	11,921 -869	-7%	-$144K	0.03%	397
2014 Q1	$2.56M	Buy	+12,790	New	+$2.56M	0.04%	359

Other funds holding ARGS

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

AWMDMG

Austin W. Marxe & David M. Greenhouse New York $733M AUM 21.72% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return

WSA

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PSI

Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.54% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Pine River Capital Management's ARGS Position: Q3 2014 in Review

Pine River Capital Management sold out of Argos Therapeutics, Inc. (ARGS) in Q3 2014, closing a stake of 11,921 shares — an estimated $1.92M sold.

Pine River Capital Management first reported a position in ARGS in Q1 2014 and held it in 2 quarters. The position peaked at $2.56M in Q1 2014. 26 funds tracked by Wall St. Rank hold ARGS as of Q3 2014.

Pine River Capital Management reported no remaining Argos Therapeutics, Inc. position as of Q3 2014 after selling out during the quarter.
Pine River Capital Management sold 11,921 Argos Therapeutics, Inc. shares in Q3 2014, an estimated $1.92M.
Pine River Capital Management first reported a position in Argos Therapeutics, Inc. in Q1 2014 and held it in 2 quarters.
Pine River Capital Management's Argos Therapeutics, Inc. position peaked at $2.56M in Q1 2014.
26 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q3 2014.

Based on Pine River Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.